Purdue's Anti-Abuse OxyContin Patent Claims Found Invalid
A New York federal judge on Wednesday ruled that although Amneal Pharmaceuticals LLC infringed Purdue Pharma LP's patent with its generic version of an abuse-resistant variety of the pain medication OxyContin,...To view the full article, register now.
Already a subscriber? Click here to view full article